ESR1 and breast cancer: The current mouse models of ER+ BC often rely on supplemented estrogen to encourage metastasis, which modifies the immune system and the function of some tissues (like bone), or use genetically modified or immunocompromised mouse strains, which do not accurately replicate the clinical disease.